KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Non Operating Investment Income: 2009-2025

Historic Non Operating Investment Income for Ionis Pharmaceuticals (IONS) over the last 12 years, with Sep 2025 value amounting to $29.9 million.

  • Ionis Pharmaceuticals' Non Operating Investment Income rose 3302.50% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 1524.07%. This contributed to the annual value of -$2.9 million for FY2024, which is 50.94% down from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Non Operating Investment Income stood at $29.9 million, which was up 263.32% from -$18.3 million recorded in Q2 2025.
  • Ionis Pharmaceuticals' 5-year Non Operating Investment Income high stood at $29.9 million for Q3 2025, and its period low was -$18.3 million during Q2 2025.
  • In the last 3 years, Ionis Pharmaceuticals' Non Operating Investment Income had a median value of -$529,000 in 2023 and averaged $420,727.
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first tumbled by 1,495.03% in 2024, then skyrocketed by 3,302.50% in 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Non Operating Investment Income (Quarterly) stood at $5.2 million in 2021, then crashed by 37.08% to $3.3 million in 2022, then tumbled by 104.90% to -$161,000 in 2023, then tumbled by 1,495.03% to -$2.6 million in 2024, then skyrocketed by 3,302.50% to $29.9 million in 2025.
  • Its Non Operating Investment Income stands at $29.9 million for Q3 2025, versus -$18.3 million for Q2 2025 and -$2.2 million for Q1 2025.